Pancreaze Capsule, Delayed Release
Product Images NDC 62541-402

6 FDA label images from Vivus Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pancreaze (NDC 62541-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vivus Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 62541-402-10 (Ndc 62541 402 10)

Ndc 62541-402-10 (Ndc 62541 402 10)
Packaging label for PANCREAZE delayed-release capsules containing pancrelipase. The label highlights active enzyme units per capsule: Lipase 4,200 USP Units, Amylase 24,600 USP Units, and Protease 14,200 USP Units. The label states storage instructions, manufacturer Vivus LLC, barcode, and indicates 100 capsules per container. The product is a human prescription drug made in Germany.*
FDA Label Image

Ndc 62541-403-10 (Ndc 62541 403 10)

Ndc 62541-403-10 (Ndc 62541 403 10)
Packaging label for PANCREAZE delayed-release capsules by VIVUS LLC. The label shows pancrelipase as the active ingredient, with each capsule containing 10,500 USP units of lipase, 61,500 USP units of amylase, and 35,500 USP units of protease. The package includes 100 delayed-release capsules and cautions about storing to protect moisture and heat. Manufacturer details indicate production in Germany by Nordmark Pharma GmbH.*
FDA Label Image

Ndc 62541-404-10 (Ndc 62541 404 10)

Ndc 62541-404-10 (Ndc 62541 404 10)
Packaging carton label for PANCREAZE delayed-release capsules containing pancrelipase. The label indicates strength with lipase 16,800 USP Units, amylase 98,400 USP Units, and protease 56,800 USP Units per capsule. The label includes storage information, manufacturer VIVUS LLC, and a barcode. It is designed for a 100 count package and features a reserved area for lot number, expiration date, GTIN, serial number, and 2D barcode.*
FDA Label Image

Ndc 62541-405-10 (Ndc 62541 405 10)

Ndc 62541-405-10 (Ndc 62541 405 10)
The image shows the flat layout of a PANCREAZE delayed-release capsules carton packaging. It includes the product name PANCREAZE with pancrelipase as the active ingredient. The label states that each capsule contains 21,000 USP Units lipase, 83,900 USP Units amylase, and 54,700 USP Units protease. The package includes storage instructions, manufacturer details (VIVUS LLC), a barcode, and notes that the capsules are for oral use and prescription only. The carton holds 100 delayed-release capsules.*
FDA Label Image

Ndc 62541-401-10 (Ndc 62541 401 10)

Ndc 62541-401-10 (Ndc 62541 401 10)
Packaging label for PANCREAZE delayed-release capsules containing pancrelipase, manufactured by VIVUS LLC. The label displays the product name, dosage form, and enzyme content per capsule: Lipase 2,600 USP Units, Amylase 15,200 USP Units, and Protease 8,800 USP Units. The label includes storage instructions, product origin (Germany), a barcode, and prescription-only indication for 100 capsules per container.*
FDA Label Image

Ndc 62541-406-10 (Ndc 62541 406 10)

Ndc 62541-406-10 (Ndc 62541 406 10)
Packaging label for PANCREAZE delayed-release capsules containing pancrelipase with enzyme units of Lipase 37,000 USP, Amylase 149,900 USP, and Protease 97,300 USP. The label shows dosage form as delayed-release oral capsules, includes storage and handling instructions, manufacturer details (Nordmark Pharma GmbH, Germany; VIVUS LLC, USA), and a barcode. Pack size indicated is 100 delayed-release capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.